Liberum analyst Edward Thomason downgraded Oxford Biomedica to Hold from Buy with a 350 GBp price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OXBDF:
